Safety and Dose Ranging Study of Human Insulin Receptor MAb-IDUA Fusion Protein in Adults and Children With MPS I
Clinical trial NCT03053089 · COMPLETED
Trial details
- NCT number
- NCT03053089
- Sponsor
- ArmaGen, Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2018-02-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.